Friday 6 November 2026 Export ZBH’s income statement to Excel — free account

Zimmer Biomet Holdings, Inc.

ZBH Healthcare Medical Devices

Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024.

Revenue: +3.07%
EPS: −13.5%
Free cash flow: +29.8%
Total debt: −7.50%

Quarter to September 2026, against a year earlier

105.28 1.57 −1.47%

Follow ZBH

Alert me

Market cap: $20.4B
P/E: 26.5×
Fwd P/E: 18.9×
Dividend yield: 0.91%
F-score: 6/9
Altman Z: 2.38
Beneish M: −2.59
Dividend safety: 72/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Zimmer Biomet Holdings, Inc. 10-Q filed Nov 5, 2025

Fiscal Q3 2025 · Period ended Sep 30, 2025 · Filed Nov 5, 2025 · accepted 4:06 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors

Part II, Item 1A, Risk Factors, against the 10-Q filed Aug 7, 2025: no changes